A major drug testing industry organization is “sounding the alarm” amid reports that President Donald Trump may soon finalize a proposal to reschedule marijuana, arguing that the reform would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.”
Ahead of a scheduled “National Conversation on the Rescheduling of Marijuana” webinar this week, National Drug & Alcohol Screening Association (NDASA) board member Emilee Avery said in a press release that rescheduling “will dismantle critical safety measures that have protected our roads, airways, and communities for decades.”
“The guardrails implemented under President Reagan’s administration 30 years ago have been instrumental in ensuring that safety-sensitive positions, such as truck drivers, school bus drivers, and airline pilots, remain drug-free,” she said. “This decision threatens to undo all of that progress.”
A final decision hasn’t been made at this point, but multiple sources have claimed that there’s an executive order that could be issued imminently, possibly directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).
Cannabis industry stakeholders are holding out hope that the reform will be achieved as soon as possible, but opponents—including NDASA and
Read full article on Marijuana Moment
